ArticleBioinformatics (Oxford, England)2024
Causal enhanced drug-target interaction prediction based on graph generation and multi-source information fusion.
Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- From past to future: Digital approaches to success of clinical drug trials for Parkinson's disease.Journal of Parkinson's disease · 2026Review
- A Node-Adaptive Feature Fusion Network for Drug-Target Interaction Prediction Based on Multi-View Graphs.Biomolecules · 2026Article
- Machine learning for drug-target interaction prediction: A comprehensive review of models, challenges, and computational strategies.Computational and structural biotechnology journal · 2026Review
- PLiSAGE: enhancing protein-ligand interaction prediction with multimodal surface and geometry encoding.Bioinformatics (Oxford, England) · 2025Article
- scKGBERT: a knowledge-enhanced foundation model for single-cell transcriptomics.Genome biology · 2025Article
- [A heterogeneous graph method integrating multi-layer semantics and topological information for improving drug-target interaction prediction].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025Article
- Machine Learning for Multi-Target Drug Discovery: Challenges and Opportunities in Systems Pharmacology.Pharmaceutics · 2025Review
- Bind: large-scale biological interaction network discovery through knowledge graph-driven machine learning.Journal of translational medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
motivationThe prediction of drug-target interaction is a vital task in the biomedical field, aiding in the discovery of potential molecular targets of drugs and the development of targeted therapy methods with higher efficacy and fewer side effects. Although there are various methods for drug-target interaction (DTI) prediction based on heterogeneous information networks, these methods face challenges in capturing the fundamental interaction between drugs and targets and ensuring the interpretability of the model. Moreover, they need to construct meta-paths artificially or a lot of feature engineering (prior knowledge), and graph generation can fuse information more flexibly without meta-path selection.
resultsWe propose a causal enhanced method for drug-target interaction (CE-DTI) prediction that integrates graph generation and multi-source information fusion. First, we represent drugs and targets by modeling the fusion of their multi-source information through automatic graph generation. Once drugs and targets are combined, a network of drug-target pairs is constructed, transforming the prediction of drug-target interactions into a node classification problem. Specifically, the influence of surrounding nodes on the central node is separated into two groups: causal and non-causal variable nodes. Causal variable nodes significantly impact the central node's classification, while non-causal variable nodes do not. Causal invariance is then used to enhance the contrastive learning of the drug-target pairs network. Our method demonstrates excellent performance compared with other competitive benchmark methods across multiple datasets. At the same time, the experimental results also show that the causal enhancement strategy can explore the potential causal effects between DTPs, and discover new potential targets. Additionally, case studies demonstrate that this method can identify potential drug targets. AVAILABILITY AND IMPLEMENTATION: The source code of AdaDR is available at: https://github.com/catly/CE-DTI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.